Hideki Aizaki Selected Research

Hideki Aizaki Research Topics

Disease

36	Infections 10/2023 - 08/2005
6	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 03/2003
5	Hepatitis B 01/2022 - 11/2013
5	Virus Diseases (Viral Diseases) 01/2019 - 03/2008
4	Hepatitis A (Hepatitis, Infectious) 10/2016 - 09/2003
2	Neoplasms (Cancer) 01/2022 - 10/2020
2	Hepatitis C 01/2022 - 01/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2013 - 04/2011
1	Merkel Cell Carcinoma 01/2022
1	Needlestick Injuries (Needlestick Injury) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Carcinogenesis 01/2021
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 10/2020
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Tremor (Tremors) 10/2019
1	Acute Liver Failure (Fulminant Hepatic Failure) 10/2019
1	Measles 01/2019
1	Reinfection 12/2015
1	Dengue (Dengue Fever) 01/2014
1	Chronic Hepatitis C 01/2014
1	Yellow Fever 01/2014

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2003
8	Antiviral Agents (Antivirals)IBA 01/2022 - 11/2013
5	sodium-bile acid cotransporterIBA 11/2021 - 02/2015
4	InterferonsIBA 01/2018 - 03/2010
3	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2019
3	VaccinesIBA 01/2022 - 08/2013
3	Membrane Proteins (Integral Membrane Proteins)IBA 10/2020 - 01/2014
3	Peptides (Polypeptides)IBA 01/2019 - 01/2016
3	Viral RNAIBA 02/2015 - 08/2006
3	CholesterolIBA 01/2014 - 06/2008
2	OxysterolsIBA 10/2023 - 01/2014
2	Monoclonal AntibodiesIBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 08/2013
2	Troglitazone (Rezulin)FDA Link 11/2021 - 01/2018
2	2,4-thiazolidinedione (thiazolidinedione)IBA 11/2021 - 01/2018
2	CytokinesIBA 10/2021 - 11/2013
2	Amino Acids FDA Link 07/2020 - 01/2019
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2019 - 02/2015
2	LipidsIBA 12/2018 - 08/2005
2	ApolipoproteinsIBA 10/2016 - 10/2012
2	NucleosidesIBA 02/2015 - 03/2010
2	Neutralizing AntibodiesIBA 01/2014 - 08/2013
2	SphingolipidsIBA 12/2008 - 06/2008
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023
1	Nonsense Codon (Nonsense Mutation)IBA 01/2022
1	Viral DNAIBA 01/2022
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2022
1	exophillic acidIBA 01/2022
1	Hepatitis C AntibodiesIBA 01/2022
1	Virus ReceptorsIBA 11/2021
1	Small Interfering RNA (siRNA)IBA 10/2021
1	AntigensIBA 10/2021
1	EpitopesIBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 10/2020
1	OrnithineIBA 07/2020
1	Arginine (L-Arginine)FDA Link 07/2020
1	Urea (Carbamide)FDA LinkGeneric 07/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	BilirubinIBA 10/2019
1	ledipasvirIBA 10/2019
1	SofosbuvirIBA 10/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2019
1	Viral ProteinsIBA 01/2019
1	EnzymesIBA 11/2018
1	ImmunosorbentsIBA 11/2018
1	Immunoglobulin M (IgM)IBA 11/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2018
1	LigandsIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	CoumarinsIBA 01/2018
1	proanthocyanidinIBA 01/2017
1	Apolipoproteins AIBA 10/2016
1	vanitaracin AIBA 12/2015
1	PolyketidesIBA 12/2015
1	CD2665IBA 02/2015
1	squalestatin 1IBA 02/2015
1	YM 53601IBA 02/2015
1	ClathrinIBA 12/2014
1	Clathrin Heavy ChainsIBA 12/2014
1	p21-Activated KinasesIBA 12/2014
1	Caveolin 1IBA 12/2014
1	Claudin-1IBA 12/2014
1	flotillinsIBA 12/2014
1	ADP-Ribosylation Factor 6IBA 12/2014
1	bafilomycin A1IBA 12/2014
1	Dynamin IIIBA 12/2014
1	C-terminal binding proteinIBA 12/2014
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2014
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 11/2013
1	CollagenIBA 11/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2014
2	Bioreactors (Bioreactor) 03/2008 - 09/2003
1	Liver Transplantation 01/2022